By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.
I agree
Search Trends
SITEMAP
Copyright © 2024 CGTN. 京ICP备20000184号
Disinformation report hotline: 010-85061466
SITEMAP
Copyright © 2024 CGTN. 京ICP备20000184号
Disinformation report hotline: 010-85061466
Benikoji CholesteHelp supplements containing "beni-koji," produced by Kobayashi Pharmaceutical, a major Japanese drug maker, are pictured in Osaka on April 4, 2024. /CFP
Japanese health supplement maker Kobayashi Pharmaceutical said on Friday it was probing 76 more deaths possibly linked to its tablets containing red yeast rice, or "Benikoji", meant to lower cholesterol.
"We have received 1,656 inquiries from individuals who have sought medical attention, and have 76 cases under investigation over (a causal) connection to the deaths," it said.
Previously, five deaths were officially registered at Japan's health ministry related to the health supplement.
Osaka-based Kobayashi Pharmaceutical has been under fire for not going public quickly with problems known internally as early as January. The first public announcement came on March 22.
(With input from AFP)